Riten Kumar

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Venues

Pediatric blood & cancer

Blood advances

Blood

Boston Children's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boston Children's Hospital Jan 01 2020

United States

Physician :: Pediatrc Hematology/ Oncology

Publications

Adam Paul Yan, Chase Parsons, Gregory Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. Pediatric blood & cancer (2024)
Riten Kumar, Juliann Duzan, Emily Drake, Jennifer Dawson
A novel heterozygous frameshift c.277del p.Thr93Leufs*21 mutation in SERPINC1 associated with type 1 antithrombin deficiency. Pediatric blood & cancer 71 (6) (2024)
Adam Paul Yan, Chase Parsons, Gregory Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. Pediatric blood & cancer 71 (3) (2024)
Riten Kumar, Juliann Duzan, Emily Drake, Jennifer Dawson
A novel heterozygous frameshift c.277del p.Thr93Leufs*21 mutation in SERPINC1 associated with type 1 antithrombin deficiency. Pediatric blood & cancer (2024)
Adam Paul Yan, Chase Parsons, Gregory Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. Pediatric blood & cancer 71 (3) (2024)
Adam Paul Yan, Chase Parsons, Gregory Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. Pediatric blood & cancer 71 (3) (2024)
Riten Kumar, Juliann Duzan, Emily Drake, Jennifer Dawson
A novel heterozygous frameshift c.277del p.Thr93Leufs*21 mutation in SERPINC1 associated with type 1 antithrombin deficiency. Pediatric blood & cancer 71 (6) (2024)
Adam Paul Yan, Chase Parsons, Gregory Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. Pediatric blood & cancer 71 (3) (2024)
Riten Kumar, Juliann Duzan, Emily Drake, Jennifer Dawson
A novel heterozygous frameshift c.277del p.Thr93Leufs*21 mutation in SERPINC1 associated with type 1 antithrombin deficiency. Pediatric blood & cancer 71 (6) (2024)
Charumathi Baskaran, Stephanie A Roberts, Ellis Barrera, Sarah Pilcher, Oren Ganor, Riten Kumar
Venous thromboembolism in transgender and gender non-binary youth is rare and occurs in the setting of secondary risk factors: A retrospective cohort study. Pediatric blood & cancer (2024)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer 70 (2) (2022)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer 70 (2) (2022)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer (2022)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer 70 (2) (2022)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer 70 (2) (2022)
Adam Yan, Chase Parsons, Greg Caplan, Daniel P Kelly, Julie Duzan, Emily Drake, Riten Kumar
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatric blood & cancer 70 (2) (2022)
Alexis K Kuhn, Surbhi Saini, Joseph Stanek, Amy Dunn, Riten Kumar
Unfractionated heparin using actual body weight without dose capping in obese pediatric patients-Subgroup analysis from an observational cohort study. Pediatric blood & cancer 68 (3) (2021)
Eman Abdelghani, Jennifer Dawson, Kristin Zajo, Michelle Hallam, Amy Dunn, Riten Kumar
Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype. Pediatric blood & cancer 68 (3) (2020)
Richard T Graham, Scott L Coven, Joseph R Stanek, Ashley Folta, Ethan W Hollingsworth, Jonathan L Finlay, Riten Kumar
Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database. Pediatric blood & cancer 68 (3) (2020)
Riten Kumar, Jennifer Dawson, Elizabeth Varga, Joan T Canini, Kay L Monda, Amy L Dunn
Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatric blood & cancer 66 (9) (2019)
Riten Kumar, Joseph Stanek, Susan Creary, Amy Dunn, Sarah H O'Brien
Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study. Blood advances 2 (3) (2019)
Jennifer A Belsky, Patrick Warren, Joseph Stanek, Riten Kumar
Catheter-directed thrombolysis for submassive pulmonary embolism in children: A case series. Pediatric blood & cancer 67 (4) (2019)
Riten Kumar, Sarah H O'Brien
aPTT in children receiving UFH: time for a change? Blood 126 (18) (2016)

Riten Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Riten Kumar